Daisy Formulations Private Limited - Company Profile

It is a trading private limited company based in Narsinghpur, Madhya Pradesh, India, established in 2014.
2014 Narsinghpur, Madhya Pradesh, India Active
Last Updated:
Access Report
About Daisy Formulations Private Limited

Daisy Formulations Private Limited, a active private limited company, was established on 17 February 2014 in Narsinghpur, Madhya Pradesh, India. Engaging in other wholesale within the trade sector, it holds CIN: U24100MP2014PTC032381. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Amit Remedies Private Limited. It upholds a compliant status. Its leadership includes Amit Kumar Tamrakar (Director), Ankita Tamrakar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O. Amit Tamrakar Beside Manish Photo Studeo, Gurudwara Ro, Ad,Kandeli, Narsinghpur, Madhya Pradesh, 487001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MP2014PTC032381

  • Registration Number

    032381

  • Incorporation Date

    17 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 13 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 3.23%
  • Profit Growth **** 3.69%
  • Ebitda **** 5.20%
  • Net Worth 3.41%
  • Total Assets -28.29%
Company report

Daisy Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Daisy Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Daisy Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Amit Kumar Tamrakar Director 17 Feb 2014 Current
Ankita Tamrakar Director 17 Feb 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daisy Formulations.

Daisy Formulations Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 3.23% increase. The company also saw a slight improvement in profitability, with a 3.69% increase in profit. The company's net worth moved up by a moderate rise of 3.41%.

Daisy Formulations revenue growth over time
Daisy Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.23%
*******
*******
*******
*******
Revenue from Operations
*******
 3.32%
*******
*******
*******
*******
Total Assets
*******
 -28.29%
*******
*******
*******
*******
Profit or Loss
*******
 3.69%
*******
*******
*******
*******
Net Worth
*******
 3.41%
*******
*******
*******
*******
EBITDA
*******
 5.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daisy Formulations?

In 2017, Daisy Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Daisy Formulations?

Unlock and access historical data on people associated with Daisy Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daisy Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daisy Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daisy Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Daisy Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Daisy Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.

  • Director Appointment

    Amit Kumar Tamrakar was appointed as a Director was appointed as a Director on 17 Feb 2014 & has been associated with this company since 12 years 13 days . was recorded as a recent event.

  • Director Appointment

    Ankita Tamrakar was appointed as a Director was appointed as a Director on 17 Feb 2014 & has been associated with this company since 12 years 13 days . was recorded as a recent event.

  • Company Incorporation

    The activity Daisy Formulations Private Limited was registered on 17 Feb 2014 with Roc Gwalior & aged 12 years 13 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daisy Formulations Private Limited?

The CIN of Daisy Formulations Private Limited is U24100MP2014PTC032381.

Where is Daisy Formulations Private Limited headquartered?

Daisy Formulations Private Limited is headquartered at C/O. Amit Tamrakar Beside Manish Photo Studeo, Gurudwara Ro, Ad,Kandeli, Narsinghpur, Madhya Pradesh, 487001.

When was Daisy Formulations Private Limited incorporated?

Daisy Formulations Private Limited was incorporated on 17 February 2014.

Who are the current directors of Daisy Formulations Private Limited?

The current directors of Daisy Formulations Private Limited are

What is the primary industry of Daisy Formulations Private Limited?

The primary industry of Daisy Formulations Private Limited is Trade.

Is Daisy Formulations Private Limited a listed company?

Daisy Formulations Private Limited is unlisted.

What is the capital structure of Daisy Formulations Private Limited?

The authorized capital of Daisy Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Daisy Formulations Private Limited?

The compliance status of Daisy Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available